Abstract
RATIONALE: Gene therapy holds promise for a curative mutation-independent treatment applicable to all cystic fibrosis (CF) patients. The various viral vector-based clinical trials conducted in the past have demonstrated safety and tolerance of different vectors, but none have led to a clear and persistent clinical benefit. Recent clinical breakthroughs in
... read more